Georgiamune

Thymmune

This biotechnology company develops scalable thymic cell therapies to restore immune function for patients with immunodeficiencies, autoimmune disorders, and transplant-related conditions.

Graph Therapeutics

This company develops artificial intelligence technology to create targeted therapies and biomarkers for patients with immune-mediated diseases.

Regcell

This biotechnology company develops regulatory T-cell therapies using an epigenetic reprogramming platform to treat patients with autoimmune diseases and inflammatory conditions.

Clade Therapeutics

This biotechnology company develops stem cell-derived medicines to treat patients with cancer and autoimmune diseases.

Novogaia

This biotechnology company develops fungal-derived medicines and molecular structure decoding software for pharmaceutical researchers to treat autoimmune diseases.

Imagene

This clinical-stage biotechnology company develops therapeutics for patients with immunological, autoimmune and inflammatory diseases to improve quality of life.

Evommune

This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.

Re-Aim Therapeutics

This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.